Guizhou Yibai Pharmaceutical's low P/S ratio may be due to p...

Moomoo AI Feb 3, 2024 08:26

Guizhou Yibai Pharmaceutical's low P/S ratio may be due to poor financial performance and declining revenue. The company's downward momentum and medium-term conditions form a barrier for the share price.

The Market Doesn't Like What It Sees From Guizhou Yibai Pharmaceutical Co., Ltd.'s (SHSE:600594) Revenues Yet As Shares Tumble 25%

Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates. Read more

Translate

Report

2429 Views

Comment

Moomoo AI

Moomoo AI Official Account

Your AI assistant for discovering investment opportunities.

4875

Followers

Following

11K

Visitors